Antonios Douros

Has grant

Adjunct Professor

McGill University

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Antonios Douros is an Adjunct Professor at McGill University in Canada. His research primarily focuses on pharmacoepidemiology, drug interactions, and health equity, addressing critical issues such as drug efficacy biomarkers and the evaluation of health frameworks in diverse populations. His recent publications include in-depth studies on drug-drug interactions, masking effects in pharmacovigilance, and the safety of anticoagulant use in patients with pre-existing conditions.

Recent Grants

Grant: Close

Comparative Effectiveness of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin for the Prevention of Micro- and Macrovascular Complications Among Patients with Type 1 Diabetes

Open Date: 2023-04-01

Close Date: 2026-03-31

Grant: Close

Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer's disease

Open Date: 2022-10-01

Close Date: 2024-09-30

Grant: Close

Effectiveness and safety of medications in vulnerable populations

Open Date: 2022-01-01

Close Date:

Grant: Close

Efficacité et innocuité des médicaments dans les populations vulnérables

Open Date: 2021-04-01

Close Date: 2025-03-31

Grant: Close

A personalized dynamic blood pressure control plan for cardiovascular disease prevention among patients with hypertension at low cardiovascular disease risk.

Open Date: 2020-04-01

Close Date: 2022-03-31

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Jakob Wested

Københavns Universitet

DENMARK

View details

Natalie Ebert

Charité - Universitätsmedizin Berlin

GERMANY

View details

Nina Mielke

Charité - Universitätsmedizin Berlin

GERMANY

View details

Kristian Filion

Associate Professor

McGill University

CANADA

View details

Tianze Jiao

Assistant Professor

University of Florida

UNITED STATES

View details

Paul Brassard

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Antonios Douros

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (23)

Advancing Health Equity in Europe

CTRH as Biomarker of Drug Efficacy: In-Depth Assessment of Real-World Evidence

Evaluation of Drug–Drug Interactions in Pharmacoepidemiologic Research

Masking in Active Comparator Designs in Pharmacovigilance: A Retrospective Bias Analysis on the Spontaneous Reporting of Thiazolidinediones and Cardiovascular Events

Diagnostic Validity of Chronic Kidney Disease in Health Claims Data Over Time: Results from a Cohort of Community-Dwelling Older Adults in Germany.

Comparators in Pharmacovigilance: A Quasi-Quantification Bias Analysis

Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population‐based cohort study

Opioid Use and the Risk of Ventricular Arrhythmias: A Systematic Review and Meta‐Analysis

Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort study

Methodological Considerations on the Use of Cohort Designs in Drug-Drug Interaction Studies in Pharmacoepidemiology

Incretin‐based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta‐analysis of observational studies

The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia

Kidney Measures and Risk of Incident Heart Failure Among Older Adults: Population-based Prospective Cohort Study.

Kidney function estimators for drug dose adjustment of direct oral anticoagulants in older adults with atrial fibrillation

Considerations on the use of different comparators in pharmacovigilance: A methodological review

Pharmacologic Heterogeneity and Risk of Severe Hypoglycemia with Concomitant Use of Sulfonylureas and DPP‐4 Inhibitors: Population‐Based Cohort Study

Concomitant use of statins and sodium‐glucose co‐transporter 2 inhibitors and the risk of myotoxicity reporting: A disproportionality analysis

Adherence and Quality of Life in Non-Valvular Atrial Fibrillation With Direct Oral Anticoagulants Versus Vitamin K Antagonists: A Systematic Review

Sulphonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: A population‐based cohort study

Common Vaccines and the Risk of Incident Dementia: A Population-based Cohort Study

Use of a Statistical Adaptive Treatment Strategy Approach for Emulating Randomized Controlled Trials Using Observational Data: The Example of Blood Pressure Control Strategies for the Prevention of Cardiovascular Events Among Individuals with Hypertension at High Cardiovascular Risk.

Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study

KIDNEY FUNCTION ESTIMATORS FOR DRUG DOSE ADJUSTMENT OF DIRECT ORAL ANTICOAGULANTS IN OLDER ADULTS WITH ATRIAL FIBRILLATION

Collaborators (6)

Jakob Wested

Natalie Ebert

Nina Mielke

Kristian Filion

Tianze Jiao

Paul Brassard

Make your next move.